FI61490C - Foerfarande foer rening av insulin dess analoger och derivat - Google Patents
Foerfarande foer rening av insulin dess analoger och derivat Download PDFInfo
- Publication number
- FI61490C FI61490C FI772023A FI772023A FI61490C FI 61490 C FI61490 C FI 61490C FI 772023 A FI772023 A FI 772023A FI 772023 A FI772023 A FI 772023A FI 61490 C FI61490 C FI 61490C
- Authority
- FI
- Finland
- Prior art keywords
- insulin
- buffer
- nacl
- och
- analoger
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title description 77
- 102000004877 Insulin Human genes 0.000 title description 38
- 108090001061 Insulin Proteins 0.000 title description 38
- 229940125396 insulin Drugs 0.000 title description 37
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 40
- 239000000872 buffer Substances 0.000 description 30
- 239000011780 sodium chloride Substances 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 229920005654 Sephadex Polymers 0.000 description 8
- 239000012507 Sephadex™ Substances 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 239000003599 detergent Substances 0.000 description 7
- 150000002191 fatty alcohols Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- 239000003792 electrolyte Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920000151 polyglycol Polymers 0.000 description 6
- 239000010695 polyglycol Substances 0.000 description 6
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 5
- 239000007979 citrate buffer Substances 0.000 description 5
- 238000004255 ion exchange chromatography Methods 0.000 description 5
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000008033 biological extinction Effects 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- DPEYHNFHDIXMNV-UHFFFAOYSA-N (9-amino-3-bicyclo[3.3.1]nonanyl)-(4-benzyl-5-methyl-1,4-diazepan-1-yl)methanone dihydrochloride Chemical compound Cl.Cl.CC1CCN(CCN1Cc1ccccc1)C(=O)C1CC2CCCC(C1)C2N DPEYHNFHDIXMNV-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- -1 NaCl Chemical class 0.000 description 1
- 241000932075 Priacanthus hamrur Species 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000012836 macromolecular constituent Substances 0.000 description 1
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/32—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from hydrolysates of wood or straw
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/854—Glands
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2629568 | 1976-07-01 | ||
| DE2629568A DE2629568C3 (de) | 1976-07-01 | 1976-07-01 | Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI772023A7 FI772023A7 (enExample) | 1978-01-02 |
| FI61490B FI61490B (fi) | 1982-04-30 |
| FI61490C true FI61490C (fi) | 1982-08-10 |
Family
ID=5981950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI772023A FI61490C (fi) | 1976-07-01 | 1977-06-29 | Foerfarande foer rening av insulin dess analoger och derivat |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4129560A (enExample) |
| JP (1) | JPS535101A (enExample) |
| AT (1) | AT352922B (enExample) |
| AU (1) | AU509110B2 (enExample) |
| BE (1) | BE856385A (enExample) |
| CA (1) | CA1086308A (enExample) |
| CH (1) | CH626051A5 (enExample) |
| DE (1) | DE2629568C3 (enExample) |
| DK (1) | DK149201C (enExample) |
| ES (1) | ES460099A1 (enExample) |
| FI (1) | FI61490C (enExample) |
| FR (1) | FR2356630A1 (enExample) |
| GB (1) | GB1582056A (enExample) |
| GR (1) | GR78333B (enExample) |
| IE (1) | IE44766B1 (enExample) |
| IT (1) | IT1080658B (enExample) |
| NL (1) | NL188804C (enExample) |
| NO (1) | NO145692C (enExample) |
| NZ (1) | NZ184516A (enExample) |
| PT (1) | PT66751B (enExample) |
| SE (1) | SE440507B (enExample) |
| ZA (1) | ZA773964B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4701521A (en) * | 1978-07-17 | 1987-10-20 | The Trustees Of Boston University | Method of effecting cellular uptake of molecules |
| US4783441A (en) * | 1979-04-30 | 1988-11-08 | Hoechst Aktiengesellschaft | Aqueous protein solutions stable to denaturation |
| US4292041A (en) * | 1979-11-02 | 1981-09-29 | Merck & Co., Inc. | Surfactant assay |
| US4459226A (en) * | 1982-02-26 | 1984-07-10 | Eli Lilly And Company | Process for recovering insulin |
| US4839341A (en) * | 1984-05-29 | 1989-06-13 | Eli Lilly And Company | Stabilized insulin formulations |
| DE3511269A1 (de) * | 1985-04-12 | 1986-10-09 | Veb Berlin-Chemie, Ddr 1199 Berlin | Verfahren zur reinigung von insulin |
| JPS6230956A (ja) * | 1985-07-31 | 1987-02-09 | Sumitomo Chem Co Ltd | 合成ペプチド類に含有されるイオン類の分析法 |
| DE3726655A1 (de) * | 1987-08-11 | 1989-02-23 | Hoechst Ag | Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten |
| JPH07119767B2 (ja) * | 1989-03-07 | 1995-12-20 | 積水化学工業株式会社 | 梅毒検査用試薬及びその製造法 |
| DE4028120C2 (de) * | 1990-09-05 | 1996-09-19 | Hoechst Ag | Verfahren zur Reinigung von Insulin und/oder Insulinderivaten |
| ES2099193T3 (es) * | 1991-12-18 | 1997-05-16 | Hoechst Ag | Procedimiento para la obtencion de soluciones con contenido en insulina. |
| US6444788B1 (en) * | 1999-03-15 | 2002-09-03 | Novo Nordisk A/S | Ion exchange chromatography of GLP-1, analogs and derivatives thereof |
| US6451987B1 (en) * | 1999-03-15 | 2002-09-17 | Novo Nordisk A/S | Ion exchange chromatography of proteins and peptides |
| PL1664108T3 (pl) * | 2003-08-21 | 2010-03-31 | Novo Nordisk As | Rozdzielanie polipeptydów zawierających racemizowany aminokwas |
| US20080096800A1 (en) * | 2004-03-12 | 2008-04-24 | Biodel, Inc. | Rapid mucosal gel or film insulin compositions |
| US20080090753A1 (en) | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
| US20080085298A1 (en) * | 2004-03-12 | 2008-04-10 | Biodel, Inc. | Rapid Mucosal Gel or Film Insulin Compositions |
| US8084420B2 (en) | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| US7713929B2 (en) * | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| WO2007121256A2 (en) | 2006-04-12 | 2007-10-25 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations |
| US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| AU2012213432B2 (en) | 2011-02-01 | 2016-10-13 | Novo Nordisk A/S | Purification of insulin |
| KR20140062044A (ko) | 2011-08-25 | 2014-05-22 | 에프. 호프만-라 로슈 아게 | 양이온 및 음이온 교환 크로마토그래피 방법 |
| JP6093364B2 (ja) * | 2011-09-30 | 2017-03-08 | ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ | 生体分子の精製方法 |
| CN103130868B (zh) * | 2013-03-12 | 2014-09-17 | 合肥天麦生物科技发展有限公司 | 一种蛋白质或多肽的纯化方法 |
| WO2016014325A1 (en) | 2014-07-21 | 2016-01-28 | Merck Sharp & Dohme Corp. | Chromatography process for purification of inlsulin and insulin analogs |
| KR20200080748A (ko) * | 2018-12-27 | 2020-07-07 | 주식회사 폴루스 | 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3616235A (en) * | 1968-05-16 | 1971-10-26 | Forsch Die Garungsindustrie En | Process for precipitating enzymes and enzymatic inactive proteins in solution with synthetic tanning materials |
| US3607858A (en) * | 1970-03-31 | 1971-09-21 | American Cyanamid Co | Process for preparing lyophilized human blood proteins such as gamma globulin in the presence of a nonionic surfactant |
| US3683939A (en) * | 1970-05-28 | 1972-08-15 | Wilson Pharm & Chem Corp | Proteinaceous cosmetic material for hair conditioning |
| US3907676A (en) * | 1970-07-28 | 1975-09-23 | Novo Terapeutisk Labor As | Process for purifying insulin |
| JPS5328989B2 (enExample) * | 1974-05-27 | 1978-08-17 | ||
| US4076800A (en) * | 1975-01-13 | 1978-02-28 | The Procter & Gamble Company | Protein-containing detergent compositions for protecting keratinous materials |
-
1976
- 1976-07-01 DE DE2629568A patent/DE2629568C3/de not_active Expired
-
1977
- 1977-06-24 NL NLAANVRAGE7707037,A patent/NL188804C/xx not_active IP Right Cessation
- 1977-06-25 ES ES460099A patent/ES460099A1/es not_active Expired
- 1977-06-28 CH CH792577A patent/CH626051A5/de not_active IP Right Cessation
- 1977-06-28 GR GR53823A patent/GR78333B/el unknown
- 1977-06-29 IT IT25221/77A patent/IT1080658B/it active
- 1977-06-29 US US05/810,979 patent/US4129560A/en not_active Expired - Lifetime
- 1977-06-29 FI FI772023A patent/FI61490C/fi not_active IP Right Cessation
- 1977-06-29 NZ NZ184516A patent/NZ184516A/xx unknown
- 1977-06-30 CA CA000281825A patent/CA1086308A/en not_active Expired
- 1977-06-30 AT AT466377A patent/AT352922B/de not_active IP Right Cessation
- 1977-06-30 SE SE7707612A patent/SE440507B/xx not_active IP Right Cessation
- 1977-06-30 DK DK293277A patent/DK149201C/da not_active IP Right Cessation
- 1977-06-30 GB GB27395/77A patent/GB1582056A/en not_active Expired
- 1977-06-30 IE IE1358/77A patent/IE44766B1/en not_active IP Right Cessation
- 1977-06-30 PT PT66751A patent/PT66751B/pt unknown
- 1977-06-30 ZA ZA00773964A patent/ZA773964B/xx unknown
- 1977-06-30 NO NO772318A patent/NO145692C/no unknown
- 1977-06-30 AU AU26604/77A patent/AU509110B2/en not_active Expired
- 1977-07-01 BE BE179012A patent/BE856385A/xx not_active IP Right Cessation
- 1977-07-01 FR FR7720310A patent/FR2356630A1/fr active Granted
- 1977-07-01 JP JP7797677A patent/JPS535101A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI61490B (fi) | Foerfarande foer rening av insulin dess analoger och derivat | |
| Bentley et al. | Action of nitrogen trichloride on proteins: progress in the isolation of the toxic factor | |
| Farrell et al. | Analysis of Phosphorylation of Protein Synthesis Initiation Factor eIF‐2 by Two‐Dimensional Gel Electrophoresis | |
| Wiberg et al. | The binding of bivalent metals by deoxyribonucleic and ribonucleic acids | |
| Kelmers | Preparation of a highly purified phenylalanine transfer ribonucleic acid | |
| Zull et al. | Studies with Tritiated Polypeptide Hormones: I. THE PREPARATION AND PROPERTIES OF AN ACTIVE, HIGHLY TRITIATED DERIVATIVE OF PARATHYROID HORMONE: ACETAMIDINO-PARATHYROID HORMONE | |
| NL8501105A (nl) | Werkwijze voor de zuivering van insuline. | |
| Expert-Bezançon et al. | Identification of neighbouring proteins in Escherichia coli 30 S ribosome subunits | |
| Arnon et al. | Crystalline papain derivative containing an intramolecular mercury bridge | |
| Gordon et al. | An electrophoretic investigation of the mixture of oligonucleotides formed by the enzymic degradation of deoxyribonucleic acid by deoxyribonuclease | |
| King et al. | Countercurrent Distribution Studies with Ribonuclease and Lysozyme | |
| EP0013826A1 (en) | Process for purifying insulin and insulin so prepared | |
| Black et al. | The Recovery of Norleucine from Casein after Administering NORLEUCINE-3-C14 to Intact COWS1 | |
| Lipps et al. | Studies on the histones of the ciliate Stylonychia mytilus | |
| Sigrist-Nelson et al. | Purification of the chloroplast-membrane dicyclohexylcarbodi-imide-binding proteolipid by ion-exchange chromatography | |
| KR800000970B1 (ko) | 고분자량의 펩타이드의 정제 방법 | |
| US3687833A (en) | Purification of lactogen | |
| Petrovic et al. | A new general method for separation of nucleic acids | |
| Blauer et al. | The effect of ions on the enzymatic properties of beef‐liver glutamate dehydrogenase | |
| Rokugawa et al. | The role of zinc atoms in nuclease P1 | |
| Gruss et al. | Amino‐Acid Composition of the Covalent Rigid‐Layer Lipoprotein in Cell Walls of Proteus mirabilis | |
| Lavrik et al. | Phenylalanyl-tRNA synthetase from E. coli MRE-600: Localization of the phenylalanine binding sites on the subunits by affinity reagents | |
| Offord et al. | Diazoalkanes in peptide semisynthesis | |
| DE1966573C3 (de) | Verfahren zur Reinigung von Insulin | |
| Aimoto et al. | Influence of anhydrous hydrogen fluoride on hen egg-white lysozyme. II. Effects on reduced hen egg-white lysozyme. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired | ||
| MA | Patent expired |
Owner name: HOECHST AKTIENGESELLSCHAFT |